Gatekeeping procedures in dose-response clinical trials based on the Dunnett test

被引:22
|
作者
Dmitrienko, Alex
Offen, Walt
Wang, Ouhong
Xia, Dan
机构
[1] Eli Lilly & Co, Lilly Corp Ctr, Lilly Res Labs, Indianapolis, IN 46285 USA
[2] Amgen Inc, Thousand Oaks, CA 91320 USA
[3] Wyeth Global Biostat, Collegeville, PA USA
关键词
multiple testing; gatekeeping tests;
D O I
10.1002/pst.190
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
This paper discusses multiple testing procedures in dose-response clinical trials with primary and secondary endpoints. A general gatekeeping framework for constructing multiple tests is proposed, which extends the Dunnett test [Journal of the American Statistical Association 1955; 50: 1096-1121] and Bonferroni-based gatekeeping tests developed by Dmitrienko et al. [Statistics in Medicine 2003; 22:2387-2400]. The proposed procedure accounts for the hierarchical structure Of the testing problem; for example, it restricts testing of secondary endpoints to the doses for which the primary endpoint is significant. The multiple testing approach is illustrated using a dose-response clinical trial in patients with diabetes. Monte-Carlo simulations. demonstrate that the proposed procedure provides a power advantage over the Bonferroni gatekeeping procedure. The power gain generally increases with increasing correlation among the endpoints, especially when all primary dose-control comparisons are significant. Copyright (C) 2006 John Wiley & Sons, Ltd.
引用
收藏
页码:19 / 28
页数:10
相关论文
共 50 条
  • [41] THE PRESSOR DOSE-RESPONSE IN CLINICAL CARDIOVASCULAR PHARMACOLOGY
    SUMNER, DJ
    ELLIOTT, HL
    BRITISH JOURNAL OF CLINICAL PHARMACOLOGY, 1987, 23 (05) : 499 - 503
  • [42] DOSE-RESPONSE RELATIONSHIP IN EXPERIMENTAL AND CLINICAL ONCOLOGY
    BRADE, WP
    FREIREICH, EJ
    GOLDIN, A
    CANCER TREATMENT REVIEWS, 1984, 11 (04) : 279 - 283
  • [43] Dose-response relationship: Relevance for clinical use
    Klinkhardt, U
    Harder, S
    MEDIZINISCHE KLINIK, 1998, 93 (12) : 744 - 749
  • [44] Analysis of dose-response in flexible dose titration clinical studies
    Xu, Xu
    Yuan, Min
    Nandy, Partha
    PHARMACEUTICAL STATISTICS, 2012, 11 (04) : 280 - 286
  • [45] DOSE-RESPONSE TEST OF ISOMALTOOLIGOSACCHARIDES FOR INCREASING FECAL BIFIDOBACTERIA
    KOHMOTO, T
    FUKUI, F
    TAKAKU, H
    MITSUOKA, T
    AGRICULTURAL AND BIOLOGICAL CHEMISTRY, 1991, 55 (08): : 2157 - 2159
  • [46] Privacy-preserving Dose-Response Relationship Test
    Kikuchi, Hiroaki
    Sato, Tomoki
    Sakuma, Jun
    2014 17TH INTERNATIONAL CONFERENCE ON NETWORK-BASED INFORMATION SYSTEMS (NBIS 2014), 2014, : 504 - 508
  • [47] Dose-response aspects in the clinical assessment of the hypothalamopituitary-adrenal axis, and the low-dose adrenocorticotropin test
    Oelkers, W
    EUROPEAN JOURNAL OF ENDOCRINOLOGY, 1996, 135 (01) : 27 - 33
  • [48] DOSE-RESPONSE AND CONCENTRATION RESPONSE RELATIONSHIPS - CLINICAL AND REGULATORY PERSPECTIVES
    LIEBERMAN, R
    NELSON, R
    THERAPEUTIC DRUG MONITORING, 1993, 15 (06) : 498 - 502
  • [49] Determination and Clinical Verification of Dose-response Relations in Clinical Radiotherapy
    Papanikolaou, N.
    Lind, B. K.
    Stathakis, S.
    Dzintars, E.
    Giantsoudi, D.
    Mavroidis, P.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2009, 75 (03): : S136 - S136
  • [50] A comparison of several methods to test for the existence of a monotonic dose-response relationship in clinical and epidemiological studies
    Leuraud, K
    Benichou, J
    STATISTICS IN MEDICINE, 2001, 20 (22) : 3335 - 3351